Nobel author Mo Yan's debut drama 'Crocodile' to premiere in May

By Li Ping | chinadaily.com.cn | Updated: 2024-01-19 16:42
Share
Share - WeChat
College students from several universities in Beijing spoke aloud lines and shared their sentiments about novelist and playwright Mo Yan's newest drama, Crocodile, at the Beiguo Theater in Beijing Normal University on Jan 11, 2023. [Photo provided to chinadaily.com.cn]

"A dreamer's nightmare, are we all slaves to desire?"
"The crocodile is in the river; the river is in my heart, and I am in the belly of the crocodile." "Don't be controlled by desire. We need light!"…

As college students spoke aloud lines and shared their sentiments about novelist and playwright Mo Yan's newest drama, Crocodile, the unveiling of the play took center stage at the Beiguo Theater in Beijing Normal University on Jan 11.

The drama, produced by Magnificent Culture Co Ltd and scripted by Mo Yan, will premiere in Suzhou, East China's Jiangsu province, on May 3, followed by a national tour until September.

Crocodile is the first original drama script penned by the Nobel laureate Mo Yan. Celebrated for his imaginative and humanistic fiction, Mo won the Nobel Prize for Literature in 2012.

Mo spent over a decade meticulously crafting the story of Crocodile. Its plot revolves around the protagonist, Shan Wudan, and a crocodile he received as a gift for his birthday. Through an infinitely growing crocodile, the story digs into the complexity of human nature and explores the theme of "desire".

1 2 3 Next   >>|
Photo

Related Stories

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US